RxDoctor Payments Data

Lela Torres, MD

Family Medicine · Apopka, FLNPI 1033376918

Payments from drug & device makers

$1,593in general payments, 2019–2025

Across 83 payments — averaging $19.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$371
  • Boehringer Ingelheim$209
  • GSK$182
  • Sanofi-aventis U.S. LLC$152
  • Pfizer$133
  • Lilly USA, LLC$123
  • plus $424 from 10 others

What the payments were for

  • Food & beverage$1,593100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,593 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$14,536
Medicare patients
41
Services billed
247

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide141$193,444
EliquisApixaban98$125,564
JardianceEmpagliflozin86$105,307
Trelegy ElliptaFluticasone/Umeclidin/Vilanter59$70,236
FarxigaDapagliflozin Propanediol34$45,524
TrulicityDulaglutide31$45,382
EntrestoSacubitril/Valsartan29$36,009
LinzessLinaclotide32$32,628
Soliqua 100-33Insulin Glargine/Lixisenatide21$25,135
Breo ElliptaFluticasone/Vilanterol40$22,510
TradjentaLinagliptin17$22,233
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$15,328
Tresiba Flextouch U-200Insulin Degludec18$14,245
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$13,417
BrilintaTicagrelor22$12,531

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$108$193,444141 claims
Boehringer IngelheimJardiance, Tradjenta$209$127,540103 claims
PfizerEliquis$133$125,56498 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$182$106,164114 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta, Symbicort$371$79,14983 claims
Lilly USA, LLCTrulicity$123$45,38231 claims
Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus$152$26,81436 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Apopka

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →